Showing results (91-100 of 315) with videos related to
Sort By:
Pageof 32
Pathophysiology of Haemostasis and Thrombosis|January 25, 2006
A model for the formation and lysis of blood clotsM Anand, K Rajagopal, K R RajagopalPathophysiology of Haemostasis and Thrombosis|January 25, 2006
Blood coagulation and propagation of autowaves in flowElena A Ermakova, Mikhail A Panteleev, Emmanuil E ShnolPathophysiology of Haemostasis and Thrombosis|November 19, 2003
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatinA Trifiletti, A Lasco, R Scamardi, et al.Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet activation markers in patients with venous thromboembolism without predisposing factorsFrank Gerdsen, Martin Weber, Florian Langer, et al.Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stressM Matsumoto, S Kawaguchi, H Ishizashi, et al.Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The evidence behind inhibitor treatment with porcine factor VIIIChristine A LeePathophysiology of Haemostasis and Thrombosis|September 6, 2002
The evidence behind inhibitor treatment with recombinant factor VIIaChristopher A LudlamPathophysiology of Haemostasis and Thrombosis|September 6, 2002
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitorsOwen P SmithPathophysiology of Haemostasis and Thrombosis|September 6, 2002
High cost patients and the consortium approachSusan Schonfield, Keith ReidPathophysiology of Haemostasis and Thrombosis|September 6, 2002
Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancerGregorios A Paspatis, Aikaterini Sfyridaki, Nikolaos Papanikolaou, et al.Pageof 32